Angela Rivers • UCSF Profiles (original) (raw)

  1. Relation of Adverse Childhood Experiences to Clinical and Patient-Reported Outcomes for Adults With Sickle Cell Disease: A Registry Study. Pediatr Blood Cancer. 2026 Feb; 73(2):e70080. Treadwell M, Liang J, Preiss L, Rivers A, Hankins JS, King A, Williams J, Potter MB, Hessler D. PMID: 41454801.
    View in: PubMed Mentions:
  2. Role of Menstrual Bleeding Assessments in Sickle Cell Clinics. JAMA Netw Open. 2025 Dec 01; 8(12):e2546345. Rush G, Mohamed RE, Moffatt-Bazile K, Jamalapur SL, Valenti GG, Sathi BK, Jacob S, Van Doren LN, Velez MC, Ogu U, Smink GM, Schultz CL, DiVirgilio N, Gomez E, Quarmyne MO, Light J, Gupta K, Zhang L, Vichinsky EP, Hagar W, Rivers A, Treadwell M, Strouse JJ, Bhasin N. PMID: 41364436; PMCID: PMC12690426.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  3. International variations in body mass index within the CASiRe global cohort of sickle cell disease patients. J Sick Cell Dis. 2025; 2(1):yoaf040. Strunk C, Rivers A, Segbefia C, Colombatti R, Tartaglione I, Manwani D, Asare EV, Piccone CM, Boruchov D, Zempsky WT, Dankwah Boatemaa G, Mahesh Ramachandra Rao S, Akatue S, Oteng B, Owda A, Bamfo R, Wilson SR, Farooq F, Urbonya R, Barber J, Sey F, Inusa B, Antwi-Boasiako C, Andemariam B, Campbell AD. PMID: 41393099; PMCID: PMC12701789.
    View in: PubMed Mentions:
  4. Mitochondrial retention and autophagy dysregulation drive oxidative stress in sickle cell disease erythrocytes. Exp Hematol. 2025 Dec; 152:105269. Ramasamy J, Punathil Kannan PK, Dhavamani S, Palanimuthu S, Molokie R, Rivers A. PMID: 41046099; PMCID: PMC12689251.
    View in: PubMed Mentions: Fields:
    Translation:HumansCells
  5. Dual Assessment of the RBC Fraction Abnormally Retaining Mitochondria and of the RBC Mitochondrial Load Provides a New Clinical Parameter for Sickle Cell Disease Patients. EJHaem. 2025 Aug; 6(4):e70130. Soupene E, Horneman H, Alejandro M, Mohammed K, Nyansa Ansong-Ansongton YO, Rivers A. PMID: 40873469; PMCID: PMC12378695.
    View in: PubMed Mentions:
  6. Hereditary Spherocytosis with Mitochondrial Retention, Increased Oxidative Stress, and Alterations to Bioactive Membrane Lipids. J Pediatr Hematol Oncol. 2024 08 01; 46(6):e457-e462. Principe DR, Reilly P, Dhavamani S, Rivers A, Molokie R, Hsu LL, Ramasamy J. PMID: 38934620; PMCID: PMC11272435.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansCells
  7. Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises. J Womens Health (Larchmt). 2023 12; 32(12):1284-1291. Segbefia C, Campbell J, Tartaglione I, Asare EV, Andemariam B, Zempsky W, Colombatti R, Boatemaa GD, Boruchov D, Rao S, Piccone CM, Smith A, Haile H, Kim E, Wilson S, Farooq F, Urbonya R, Rivers A, Manwani D, Gai J, Sey F, Inusa B, Antwi-Boasiako C, Strunk C, Campbell AD. PMID: 38011013; PMCID: PMC10712351.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  8. Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF. Blood Adv. 2023 08 08; 7(15):3891-3902. Ibanez V, Vaitkus K, Zhang X, Ramasamy J, Rivers AE, Saunthararajah Y, Molokie R, Lavelle D. PMID: 36884303; PMCID: PMC10405201.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansAnimals
  9. Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia. Exp Hematol. 2023 06; 122:55-62. Gallivan A, Alejandro M, Kanu A, Zekaryas N, Horneman H, Hong LK, Vinchinsky E, Lavelle D, Diamond AM, Molokie RE, Ramasamy J, Rivers A. PMID: 36934777.
    View in: PubMed Mentions: 11 Fields:
    Translation:HumansAnimalsCells
  10. Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana. Pain Med. 2022 08 01; 23(8):1379-1386. Zempsky WT, Yanaros M, Sayeem M, Boruchov D, Piccone CM, Manwani D, Strunk C, Tartaglione I, Colombatti R, Akatue S, Oteng B, Owda A, Bamfo R, Wilson S, Rivers A, Farooq F, Urbonya R, Boatemaa GD, Rao S, Inusa B, Antwi-Boasiako C, Segbefia C, Sey F, Andemariam B, Asare EV, Campbell AD. PMID: 35166851.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  11. Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort. Blood Cells Mol Dis. 2021 12; 92:102612. Strunk C, Tartaglione I, Piccone CM, Colombatti R, Andemariam B, Manwani D, Smith A, Haile H, Kim E, Wilson S, Asare EV, Rivers A, Farooq F, Urbonya R, Boruchov D, Boatemaa GD, Perrotta S, Ekem I, Sainati L, Rao S, Zempsky W, Sey F, Antwi-Boasiako C, Segbefia C, Inusa B, Campbell AD. PMID: 34564050; PMCID: PMC8643307.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans
  12. T-cell large granular lymphocytic leukemia successfully treated with oral cyclosporine in a child: Case report and review of literature. Pediatr Blood Cancer. 2020 12; 67(12):e28487. Mittal N, Loughran T, Rivers A. PMID: 32589344.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  13. An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research. J Racial Ethn Health Disparities. 2021 02; 8(1):99-106. Campbell AD, Colombatti R, Andemariam B, Strunk C, Tartaglione I, Piccone CM, Manwani D, Asare EV, Boruchov D, Farooq F, Urbonya R, Boatemaa GD, Perrotta S, Sainati L, Rivers A, Rao S, Zempsky W, Sey F, Segbefia C, Inusa B, Antwi-Boasiako C. PMID: 32418182; PMCID: PMC7669607.
    View in: PubMed Mentions: 12 Fields:
    Translation:Humans
  14. A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis. Ann Hematol. 2020 Sep; 99(9):2073-2079. Antwi-Boasiako C, Andemariam B, Colombatti R, Asare EV, Strunk C, Piccone CM, Manwani D, Boruchov D, Farooq F, Urbonya R, Wilson S, Boatemaa GD, Perrotta S, Sainati L, Rivers A, Rao S, Zempsky W, Ekem I, Sey F, Segbefia C, Inusa B, Tartaglione I, Campbell AD. PMID: 32377816; PMCID: PMC7430152.
    View in: PubMed Mentions: 13 Fields:
    Translation:Humans
  15. A new target for fetal hemoglobin reactivation. Haematologica. 2019 12; 104(12):2325-2327. Rivers A, Molokie R, Lavelle D. PMID: 31787612; PMCID: PMC6959183.
    View in: PubMed Mentions: 6 Fields:
    Translation:HumansCells
  16. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons. Exp Hematol. 2018 11; 67:60-64.e2. Rivers A, Vaitkus K, Jagadeeswaran R, Ruiz MA, Ibanez V, Ciceri F, Cavalcanti F, Molokie RE, Saunthararajah Y, Engel JD, DeSimone J, Lavelle D. PMID: 30125603; PMCID: PMC8728698.
    View in: PubMed Mentions: 9 Fields:
    Translation:AnimalsCells
  17. Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data. Am J Physiol Regul Integr Comp Physiol. 2018 10 01; 315(4):R840-R847. Rivers A, Jagadeeswaran R, Lavelle D. PMID: 30067082; PMCID: PMC6734057.
    View in: PubMed Mentions: 3 Fields:
    Translation:HumansAnimalsCells
  18. Evolving treatment paradigms in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):440-446. Jagadeeswaran R, Rivers A. PMID: 29222291; PMCID: PMC6142561.
    View in: PubMed Mentions: 14 Fields:
    Translation:HumansCells
  19. Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. Exp Hematol. 2017 06; 50:46-52. Jagadeeswaran R, Vazquez BA, Thiruppathi M, Ganesh BB, Ibanez V, Cui S, Engel JD, Diamond AM, Molokie RE, DeSimone J, Lavelle D, Rivers A. PMID: 28238805; PMCID: PMC6263958.
    View in: PubMed Mentions: 55 Fields:
    Translation:HumansAnimalsCells
  20. Efficacy and safety of long-term RN-1 treatment to increase HbF in baboons. Blood. 2017 01 12; 129(2):260-263. Ibanez V, Vaitkus K, Rivers A, Molokie R, Cui S, Engel JD, DeSimone J, Lavelle D. PMID: 27908882; PMCID: PMC5234223.
    View in: PubMed Mentions: 10 Fields:
    Translation:Animals
  21. The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis). Haematologica. 2016 06; 101(6):688-97. Rivers A, Vaitkus K, Ibanez V, Ruiz MA, Jagadeeswaran R, Saunthararajah Y, Cui S, Engel JD, DeSimone J, Lavelle D. PMID: 26858356; PMCID: PMC5013966.
    View in: PubMed Mentions: 35 Fields:
    Translation:AnimalsCells
  22. Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease. Pharmacotherapy. 2015 Jul; 35(7):696-700. Han J, Kemiki O, Hsu LL, Rivers AE. PMID: 26095207; PMCID: PMC5520624.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  23. The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice. Blood. 2015 Jul 16; 126(3):386-96. Cui S, Lim KC, Shi L, Lee M, Jearawiriyapaisarn N, Myers G, Campbell A, Harro D, Iwase S, Trievel RC, Rivers A, DeSimone J, Lavelle D, Saunthararajah Y, Engel JD. PMID: 26031919; PMCID: PMC4504950.
    View in: PubMed Mentions: 56 Fields:
    Translation:HumansAnimalsCells
  24. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model. Exp Hematol. 2015 Jul; 43(7):546-53.e1-3. Rivers A, Vaitkus K, Ruiz MA, Ibanez V, Jagadeeswaran R, Kouznetsova T, DeSimone J, Lavelle D. PMID: 25931013; PMCID: PMC6325640.
    View in: PubMed Mentions: 21 Fields:
    Translation:HumansAnimalsCells
  25. Hydroxymethylcytosine and demethylation of the γ-globin gene promoter during erythroid differentiation. Epigenetics. 2015; 10(5):397-407. Ruiz MA, Rivers A, Ibanez V, Vaitkus K, Mahmud N, DeSimone J, Lavelle D. PMID: 25932923; PMCID: PMC4622718.
    View in: PubMed Mentions: 15 Fields:
    Translation:HumansAnimalsCells
  26. Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy. Immunol Cell Biol. 2014 Feb; 92(2):116-23. Pandya J, Ortiz L, Ling C, Rivers AE, Aslanidi G. PMID: 24217810.
    View in: PubMed Mentions: 37 Fields:
    Translation:HumansCells
  27. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. Cytotherapy. 2013 Aug; 15(8):986-98. Song L, Kauss MA, Kopin E, Chandra M, Ul-Hasan T, Miller E, Jayandharan GR, Rivers AE, Aslanidi GV, Ling C, Li B, Ma W, Li X, Andino LM, Zhong L, Tarantal AF, Yoder MC, Wong KK, Tan M, Chatterjee S, Srivastava A. PMID: 23830234; PMCID: PMC3711144.
    View in: PubMed Mentions: 52 Fields:
    Translation:HumansAnimalsCells
  28. Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery. J Control Release. 2013 Oct 28; 171(2):184-92. Choe SW, Terman DS, Rivers AE, Rivera J, Lottenberg R, Sorg BS. PMID: 23871960; PMCID: PMC4162096.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansAnimalsCells
  29. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold? PLoS One. 2013; 8(3):e59142. Aslanidi GV, Rivers AE, Ortiz L, Song L, Ling C, Govindasamy L, Van Vliet K, Tan M, Agbandje-McKenna M, Srivastava A. PMID: 23527116; PMCID: PMC3602601.
    View in: PubMed Mentions: 72 Fields:
    Translation:HumansAnimalsCells
  30. High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors. Vaccine. 2012 Jun 06; 30(26):3908-17. Aslanidi GV, Rivers AE, Ortiz L, Govindasamy L, Ling C, Jayandharan GR, Zolotukhin S, Agbandje-McKenna M, Srivastava A. PMID: 22497875; PMCID: PMC3356484.
    View in: PubMed Mentions: 35 Fields:
    Translation:HumansCells
  31. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses. Hum Gene Ther. 2010 Mar; 21(3):271-83. Jayandharan GR, Zhong L, Sack BK, Rivers AE, Li M, Li B, Herzog RW, Srivastava A. PMID: 19788390; PMCID: PMC2865358.
    View in: PubMed Mentions: 26 Fields:
    Translation:HumansAnimalsCells
  32. Congenital cytopenias and bone marrow failure syndromes. Semin Perinatol. 2009 Feb; 33(1):20-8. Rivers A, Slayton WB. PMID: 19167578.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  33. Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow. J Pediatr Hematol Oncol. 2008 Sep; 30(9):708-11. Slayton WB, Patel M, Sola-Visner M, Harris N, Rivers A, Montgomery RR, Friedman KD. PMID: 18776767; PMCID: PMC5592795.
    View in: PubMed Mentions: 3 Fields:
    Translation:HumansCells
  34. Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression. Hum Gene Ther. 2008 Apr; 19(4):365-75. Maina N, Zhong L, Li X, Zhao W, Han Z, Bischof D, Aslanidi G, Zolotukhin S, Weigel-Van Aken KA, Rivers AE, Slayton WB, Yoder MC, Srivastava A. PMID: 18399730.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansAnimalsCells

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs